Total aortic arch replacement with frozen elephant trunk in patients with Marfan syndrome

Erik Beckmann1, Andreas Martens2, Heike Krueger3

  • 1Minneapolis Heart Institute, Minneapolis, MN, USA.

PubMed
Abstract

Insights

Frozen elephant trunk (FET) repair is feasible for Marfan syndrome (MFS) aortic dissections, showing acceptable early outcomes. However, high rates of re-intervention highlight the need for lifelong monitoring and management in MFS patients.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Genetics and Inherited Diseases

Background:

  • Marfan syndrome (MFS) is a genetic connective tissue disorder predisposing to aortic aneurysm and dissection.
  • The efficacy of frozen elephant trunk (FET) repair in MFS patients with complex aortic pathology remains incompletely understood.

Purpose of the Study:

  • To evaluate the outcomes of total aortic arch replacement using FET in patients with Marfan syndrome.
  • To assess the early and long-term results, including survival and re-intervention rates, following FET procedures in this specific patient cohort.

Main Methods:

  • Retrospective analysis of 34 Marfan syndrome patients who underwent FET repair between 2001 and 2021.
  • Procedures included total aortic arch replacement with FET, with various concomitant aortic root and valve surgeries.
  • Data collected on perioperative outcomes, in-hospital mortality, long-term survival, and distal aortic re-interventions.

Main Results:

  • The primary indications for FET were acute (35%) and chronic (62%) aortic dissection.
  • In-hospital mortality was 12%, with low rates of disabling stroke (6%), permanent dialysis (0%), and paraplegia (0%).
  • Long-term survival rates at 1, 5, 10, and 15 years were 82%, 70%, 70%, and 65%, respectively, with a high rate (53%) of distal aortic re-interventions.

Conclusions:

  • Frozen elephant trunk repair is a feasible and effective option for managing complex aortic pathologies in Marfan syndrome patients.
  • The procedure demonstrates acceptable early mortality and morbidity, supporting its use in this high-risk population.
  • A high incidence of late re-interventions necessitates tailored, long-term surveillance and management strategies for Marfan syndrome patients undergoing FET repair.